Stock Taper
SERA
SERA PROGNOSTICS, INC.
NASDAQ
$2.07
▲ UP 1.97% (0.04)

KEY STATISTICS

Market Cap$79.06 M
52w High$3.95
52w Low$1.56
Dividend Yield
Frequency
P/E-3.18
Volume23.11K
Shares Out.38.19M

COMPANY

LEADERSHIP

Zhenya Lindgardt
CHIEF EXECUTIVE
Zhenya Lindgardt

COMPENSATION 2026

Salary$607,000
Stock Awards$526,718
Incentive Plan Pay$392,122
All Other Comp.$14,000
Total$2,033,811

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 15, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
72

PRICE TARGET

Target High$6.00
Target Low$6.00
Target Median$6.00
Target Consensus$6.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$75.00K
NOV
12
THU

PRICE

$2.07 ▲ UP 1.97% (+$0.04)
$2.02$2.10$2.189:36 AM10:40 AM11:44 AM12:47 PM1:51 PM2:55 PM3:59 PM2.07

About Sera Prognostics, Inc.

https://www.sera.com ↗

Sera Prognostics, Inc. develops blood-based biomarker tests, including PreTRM, to predict pregnancy risks and improve outcomes for conditions like preterm birth, preeclampsia, and gestational diabetes.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT SERA PROGNOSTICS, INC. IS KNOWN FOR

PreTRM Test
PreTRM Test

The PreTRM Test is a blood-based biomarker that predicts early risk of spontaneous preterm birth in asymptomatic singleton pregnancies at 18-20 weeks, enabling personalized interventions to improve maternal and infant outcomes.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

DIRECTOR
Kamdar Kim P.
Purchase · 34.5K shares
2026-07-10
DIRECTOR
Mirza Mansoor Raza
Purchase · 22.4K shares
2026-07-10
DIRECTOR
Lawrence Sandra AJ
Purchase · 2.3K shares
2026-07-10
DIRECTOR
Lawrence Sandra AJ
Purchase · 22.4K shares
2026-07-10

SECTORS PEERS

PEERPRICE
LUCD$0.99COMPARE
SRZN$22.42COMPARE
HURA$2.11COMPARE
APYX$3.08COMPARE
CGTX$1.02COMPARE
ONCY$0.86COMPARE
RPID$1.57COMPARE
TVGN$6.89COMPARE